Skip to main
LGND
LGND logo

Ligand Pharmaceuticals (LGND) Market Capitalization Overview

Market Cap: $2.18B as of Jul 1, 2025

$2.18B
Past Month+$200.09M (10.15%)
As of Jul 1, 2025, Ligand Pharmaceuticals (LGND) has a market capitalization of $2.18B. Over the past 30 days, its market cap has increased by 10.74%, while in the last 12 months, it has increased by 7.27%.

Market capitalization represents the total value of Ligand Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Ligand Pharmaceuticals (LGND) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Ligand Pharmaceuticals (LGND) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Ligand Pharmaceuticals (LGND) Market Cap History

DateMarket CapChange
Jul 1, 2025$2.18B+10.74%
Jun 2, 2025$1.97B-6.82%
May 1, 2025$2.11B+4.27%
Apr 1, 2025$2.02B-4.78%
Mar 3, 2025$2.12B-2.25%
Feb 3, 2025$2.17B+5.85%
Jan 2, 2025$2.05B-11.64%

Ligand Pharmaceuticals (LGND) End of Year Market Cap History

DateMarket CapChange
2025$2.18B+7.27%
2024$2.03B+62.59%
2023$1.25B+10.35%
2022$1.13B-28.31%
2021$1.58B+61.40%
2020$975.33M

FAQs About Ligand Pharmaceuticals (LGND) Market Cap

As of Jul 1, 2025, the market capitalization of Ligand Pharmaceuticals (LGND) is $2.18B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Ligand Pharmaceuticals’s market capitalization has increased by 10.15%, changing from $1.98B to $2.18B as of Jul 1, 2025.

In the last 3 months, Ligand Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Ligand Pharmaceuticals’s market capitalization increased from $1.25B in January to $2.03B in December, reflecting a 62.59% change.

In the past five years, Ligand Pharmaceuticals (LGND) has had a compound annual growth rate (CAGR) of 15.73% in market capitalization. This means its market cap has grown at an average rate of 15.73% per year.

Ligand Pharmaceuticals (LGND)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.